CD4 and breast neoplasm: We initiated the study with a longitudinal survey of TCR repertoires monitored in the peripheral blood of individual mice that were in the process of spontaneously developing breast tumors; We recovered a subset of T cells based on their CD4+CD62LhiCD44lo markers.